Answer
Metyrapone Esteve is not recommended during pregnancy for diagnostic testing or endogenous Cushing’s syndrome unless benefits outweigh risks; if used, monitor maternal blood pressure and manage hypertension, and monitor neonatal cortisol and electrolytes at birth and the following week or until resolution, with glucocorticoid replacement if needed.
Sources for this answer
- Metyrapone Esteve 250 mg Soft CapsulesEsteve Pharmaceuticals (formerly Intrapharm Laboratories) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked